Type I Interferonopathies

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Type-I interferon (IFN)-mediated immune response involves both innate and adaptive immune systems and has a pivotal role in antiviral defense. The observation of an aberrant stimulation of this system as a common molecular basis in peculiar inherited autoimmune and autoinflammatory disorders led to the concept of “type I interferonopathies.” These latter diseases can be associated with recurrent fever and a large number of symptoms with an extremely broad phenotype, from an isolated increase of IFN-stimulated genes in whole blood without clinical symptoms to a severe neonatal encephalopathy. Here we review the main clinical features of this emerging entity and discuss the management for diagnosis and treatment.

Cite

CITATION STYLE

APA

Frachette, C., Cimaz, R., & Belot, A. (2020). Type I Interferonopathies. In Rare Diseases of the Immune System (pp. 247–256). Springer Nature. https://doi.org/10.1007/978-3-030-19055-2_14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free